{"id":"https://openalex.org/W4393203038","doi":"https://doi.org/10.53555/jptcp.v31i3.5177","title":"DESIGN AND DEVELOPMENT OF OPTIMIZED BERBERINE CHLORIDE FORMULATION FOR TREATMENT OF DIABETES","display_name":"DESIGN AND DEVELOPMENT OF OPTIMIZED BERBERINE CHLORIDE FORMULATION FOR TREATMENT OF DIABETES","publication_year":2024,"publication_date":"2024-03-04","ids":{"openalex":"https://openalex.org/W4393203038","doi":"https://doi.org/10.53555/jptcp.v31i3.5177"},"language":"en","primary_location":{"id":"doi:10.53555/jptcp.v31i3.5177","doi":"https://doi.org/10.53555/jptcp.v31i3.5177","is_oa":true,"landing_page_url":"http://dx.doi.org/10.53555/jptcp.v31i3.5177","pdf_url":"https://www.jptcp.com/index.php/jptcp/article/download/5177/5035","source":{"id":"https://openalex.org/S4210224141","display_name":"Journal of Population Therapeutics and Clinical Pharmacology","issn_l":"1710-6222","issn":["1710-6222","1198-581X","2561-8741"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310318016","host_organization_name":"Codon Publications","host_organization_lineage":["https://openalex.org/P4310318016"],"host_organization_lineage_names":["Codon Publications"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Population Therapeutics and Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.jptcp.com/index.php/jptcp/article/download/5177/5035","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111154649","display_name":"Ms Priya Sharma","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127512","display_name":"IEC University","ror":"https://ror.org/03kzpe032","country_code":"IN","type":"education","lineage":["https://openalex.org/I4210127512"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ms Priya Sharma","raw_affiliation_strings":["Research Scholar, IEC School of Pharmacy, IEC University, Baddi, H.P., India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Scholar, IEC School of Pharmacy, IEC University, Baddi, H.P., India","institution_ids":["https://openalex.org/I4210127512"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029653249","display_name":"Navjot Singh Sethi","orcid":"https://orcid.org/0000-0002-3804-8689","observed_orcids":["https://orcid.org/0000-0002-3804-8689"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dr Navjot Singh Sethi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.4077000021934509,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.4077000021934509,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.29319998621940613,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12059","display_name":"Berberine and alkaloids research","score":0.16529999673366547,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/berberine-chloride","display_name":"berberine chloride","score":0.9440000057220459},{"id":"https://openalex.org/keywords/phospholipid-complex","display_name":"phospholipid complex","score":0.9020000100135803},{"id":"https://openalex.org/keywords/soy-lecithin","display_name":"soy lecithin","score":0.746999979019165},{"id":"https://openalex.org/keywords/penetration-enhancers","display_name":"penetration enhancers","score":0.8460000157356262},{"id":"https://openalex.org/keywords/in-vitro-permeation","display_name":"in vitro permeation","score":0.6499999761581421},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.796999990940094},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.9350000023841858},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.8460000157356262},{"id":"https://openalex.org/keywords/quality-by-design","display_name":"quality by design","score":0.7720000147819519},{"id":"https://openalex.org/keywords/formulation-optimization","display_name":"formulation optimization","score":0.625},{"id":"https://openalex.org/keywords/drug-solubility","display_name":"drug solubility","score":0.7089999914169312}],"concepts":[{"id":"https://openalex.org/C2780116568","wikidata":"https://www.wikidata.org/wiki/Q176525","display_name":"Berberine","level":2,"score":0.8159210085868835},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5918236970901489},{"id":"https://openalex.org/C3018376624","wikidata":"https://www.wikidata.org/wiki/Q1100933","display_name":"Diabetes treatment","level":4,"score":0.5028511881828308},{"id":"https://openalex.org/C556039675","wikidata":"https://www.wikidata.org/wiki/Q771035","display_name":"Traditional medicine","level":1,"score":0.35232147574424744},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33670753240585327},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32336822152137756},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.26567667722702026},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.11439669132232666}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.53555/jptcp.v31i3.5177","doi":"https://doi.org/10.53555/jptcp.v31i3.5177","is_oa":true,"landing_page_url":"http://dx.doi.org/10.53555/jptcp.v31i3.5177","pdf_url":"https://www.jptcp.com/index.php/jptcp/article/download/5177/5035","source":{"id":"https://openalex.org/S4210224141","display_name":"Journal of Population Therapeutics and Clinical Pharmacology","issn_l":"1710-6222","issn":["1710-6222","1198-581X","2561-8741"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310318016","host_organization_name":"Codon Publications","host_organization_lineage":["https://openalex.org/P4310318016"],"host_organization_lineage_names":["Codon Publications"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Population Therapeutics and Clinical Pharmacology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.53555/jptcp.v31i3.5177","doi":"https://doi.org/10.53555/jptcp.v31i3.5177","is_oa":true,"landing_page_url":"http://dx.doi.org/10.53555/jptcp.v31i3.5177","pdf_url":"https://www.jptcp.com/index.php/jptcp/article/download/5177/5035","source":{"id":"https://openalex.org/S4210224141","display_name":"Journal of Population Therapeutics and Clinical Pharmacology","issn_l":"1710-6222","issn":["1710-6222","1198-581X","2561-8741"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310318016","host_organization_name":"Codon Publications","host_organization_lineage":["https://openalex.org/P4310318016"],"host_organization_lineage_names":["Codon Publications"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Population Therapeutics and Clinical Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.8371999859809875,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4393203038.pdf","grobid_xml":"https://content.openalex.org/works/W4393203038.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W188465938","https://openalex.org/W1494615854","https://openalex.org/W1966163938","https://openalex.org/W1967847357","https://openalex.org/W1971181330","https://openalex.org/W1980399763","https://openalex.org/W1999166183","https://openalex.org/W2006897167","https://openalex.org/W2013533376","https://openalex.org/W2020143653","https://openalex.org/W2026271711","https://openalex.org/W2028212562","https://openalex.org/W2035906180","https://openalex.org/W2062883522","https://openalex.org/W2064269909","https://openalex.org/W2078063997","https://openalex.org/W2085105898","https://openalex.org/W2091326330","https://openalex.org/W2095149904","https://openalex.org/W2112347682","https://openalex.org/W2121350284","https://openalex.org/W2272399875","https://openalex.org/W2306267508","https://openalex.org/W2352827622","https://openalex.org/W2538828182","https://openalex.org/W2615812282","https://openalex.org/W2739156782","https://openalex.org/W2761380401","https://openalex.org/W2765841571","https://openalex.org/W2767723038","https://openalex.org/W2789732774","https://openalex.org/W2803821641","https://openalex.org/W2994172485","https://openalex.org/W3003818063","https://openalex.org/W3094122303","https://openalex.org/W3094430840","https://openalex.org/W3211775389","https://openalex.org/W4200285253","https://openalex.org/W4214949543","https://openalex.org/W4361208994"],"related_works":["https://openalex.org/W2085105898","https://openalex.org/W7095135755","https://openalex.org/W2389069019","https://openalex.org/W7139948325","https://openalex.org/W7028816283","https://openalex.org/W2365572013","https://openalex.org/W7212355178","https://openalex.org/W4226255853","https://openalex.org/W4404959672","https://openalex.org/W7223464130"],"abstract_inverted_index":{"Aim:":[0],"To":[1],"design":[2,326],"and":[3,15,24,41,64,68,80,106,130,156,162,220,262,277],"development":[4,322],"of":[5,21,57,114,172,182,197,264,288,299,318,320],"optimized":[6],"berberine":[7,73,199,231,265,289],"chloride":[8],"formulation":[9,321],"by":[10,31,189,325],"using":[11,35,77,323],"the":[12,19,36,52,170,180,198,235,268,274,286,297,308,316],"phospholipid":[13,27,47,75,269,330],"complexation":[14,210],"permeation":[16,70,86,102,233],"enhancer":[17],"for":[18,51,292],"treatment":[20,298],"diabetes.":[22],"Material":[23],"methods:":[25],"The":[26,45,72,88,111,240],"complex":[28,48,76,90,184,201,270],"was":[29,49,91,187],"prepared":[30,46],"solvent":[32],"evaporation":[33],"method":[34],"soya":[37],"lecithin,":[38],"Phospholipid":[39],"90G":[40],"lipoid":[42],"S":[43],"100.":[44],"evaluated":[50,92],"physical":[53,93,248],"appearance,":[54,94],"FTIR,":[55,96],"percentage":[56,65],"drug":[58,62,66,97,209,251,276],"complexing":[59],"efficiency,":[60],"total":[61],"content":[63,252],"loading":[67],"in-vitro":[69],"study.":[71,109],"loaded":[74],"phenyl":[78,281],"piperazine":[79,82],"methyl":[81],"were":[83],"used":[84],"as":[85,122,303],"enhancer.":[87],"formulated":[89],"pH,":[95],"content,":[98],"permeability":[99,227],"study,":[100,103,310],"In-vitro":[101],"stability":[104,241],"study":[105,113,242],"In-vivo":[107,256],"pharmacokinetic":[108,257],"Results:":[110],"preformulation":[112],"Berberine":[115,133,177],"HCl":[116,134,232,266],"involved":[117],"investigating":[118],"various":[119],"parameters":[120],"such":[121,302],"organoleptic":[123],"properties,":[124],"melting":[125,144],"point,":[126,145],"partition":[127,146],"coefficient,":[128],"solubility,":[129],"absorption":[131,263],"maxima.":[132],"exhibited":[135],"a":[136,140,143,183,204,278],"yellow":[137,206],"color":[138],"with":[139,185,216,280,331],"bitter":[141],"taste,":[142],"coefficient.":[147],"Solubility":[148],"testing":[149],"revealed":[150,259],"its":[151],"sparing":[152],"solubility":[153,158,217],"in":[154,159,176,191,218,247,296],"methanol":[155],"slight":[157],"ethanol,":[160],"water,":[161],"phosphate":[163],"buffer":[164],"pH":[165],"6.8.":[166],"FTIR":[167],"analysis":[168,258],"confirmed":[169],"presence":[171],"characteristic":[173,192],"functional":[174],"groups":[175],"HCl.":[178],"Furthermore,":[179],"formation":[181],"phospholipids":[186],"indicated":[188,243],"shifts":[190],"peaks.":[193],"Physical":[194],"appearance":[195,249],"assessments":[196],"HCl-phospholipid":[200,290],"formulations":[202],"showed":[203],"consistent":[205,332],"color.":[207],"Percentage":[208],"ranged":[211],"from":[212,234,267],"56.098%":[213],"to":[214,273,328],"80.466%,":[215],"n-octanol":[219],"water":[221],"varying":[222],"across":[223],"formulations.":[224],"In":[225],"vitro":[226],"studies":[228],"demonstrated":[229],"enhanced":[230,293],"complexed":[236],"formulations,":[237],"notably":[238],"DBPC14.":[239],"no":[244],"significant":[245],"changes":[246],"or":[250],"over":[253],"three":[254],"months.":[255],"improved":[260],"bioavailability":[261],"DBPC14":[271],"compared":[272],"pure":[275],"mixture":[279],"piperazine.":[282],"These":[283],"findings":[284],"suggest":[285],"potential":[287],"complexes":[291],"therapeutic":[294],"outcomes":[295],"metabolic":[300],"disorders":[301],"diabetes":[304],"mellitus.":[305],"Conclusion:":[306],"From":[307],"present":[309],"it":[311],"can":[312],"be":[313],"concluded":[314],"that":[315],"importance":[317],"optimization":[319],"quality":[324],"strategy":[327],"achieve":[329],"quality.":[333]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-03-27T00:00:00"}